SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001176256-10-001059
Filing Date
2010-12-23
Accepted
2010-12-23 17:26:43
Documents
4
Period of Report
2009-11-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED NOVEMBER 30, 2009 - AMENDMENT NO. 1 globalbiotech10ka091130.htm 10-K/A 17106
2 SOX SECTION 302 CEO CERTIFICATION exhibit31-1.htm EX-31.1 8367
3 SOX SECTION 302 CFO CERTIFICATION exhibit31-2.htm EX-31.2 8254
4 SOX SECTION 906 CEO AND CFO CERTIFICATIONS exhibit32.htm EX-32 3529
  Complete submission text file 0001176256-10-001059.txt   38766
Mailing Address 5800 METROPOLITAN EAST SUITE 328 MONTREAL A8 H1S1A7
Business Address 5800 METROPOLITAN EAST SUITE 328 MONTREAL A8 H1S1A7 514 333 4545
Global Biotech Corp. (Filer) CIK: 0001126162 (see all company filings)

IRS No.: 980229951 | Fiscal Year End: 0228
Type: 10-K/A | Act: 34 | File No.: 000-33271 | Film No.: 101273086
SIC: 7389 Services-Business Services, NEC